Peptide based adsorbers for therapeutic immunoadsorption (Q35200787)

7 August 2017

1 reference

title

Peptide based adsorbers for therapeutic immunoadsorption (English)

1 reference

7 August 2017

7

Gerd Wallukat

1 reference

7 August 2017

8

Johannes Müller

1 reference

7 August 2017

Wolfgang Rönspeck

1

1 reference

7 August 2017

Roland Brinckmann

2

1 reference

7 August 2017

Ralf Egner

3

1 reference

7 August 2017

Frank Gebauer

4

1 reference

7 August 2017

Dirk Winkler

5

1 reference

7 August 2017

Petra Jekow

6

1 reference

7 August 2017

Rudolf Kunze

9

1 reference

7 August 2017

1 February 2003

1 reference

Therapeutic Apheresis and Dialysis

7 August 2017

1 reference

7 August 2017

7

1 reference

7 August 2017

1

1 reference

7 August 2017

91-97

1 reference

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

7 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Intravenous immunoglobulins: clinical experience and viral safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Peri-operative immunoadsorption in sensitized renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Immunoadsorption of sensitized kidney transplant candidates immediately prior to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Frequency of immediate adverse effects associated with therapeutic apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

The management of heart failure--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-0968.2003.00017.X

10.1046/J.1526-0968.2003.00017.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference